Docket Number:28A-1010214
Inventor:Shang-Cheng Hung
IP Status:US9,822,140 B2、TW I596106、CN ZL201380029680.3
Abstract:
This invention describes novel processes for the synthesis of Fondaparinux and new intermediates using commercially available and cheap D-glucose and D-glucosamine as the starting materials. The entire protocol only requires 28 synthetic steps with highly stereoselective control of all glycosidic bond formations which are much less than that disclosed in the U.S. patent 7,541,445. In addition, this convenient route eliminates the tedious purification, increases the overall yield, and lows down the cost.
Fields of Application:
Carbohydrate Chemistry, Organic Chemistry, Medicinal Chemistry
Advantages when compared to the existing technologies:
- This invention has applied the strategy of “regioselective one-pot protection” and introduced orthogonally permanent and temporary protecting groups. The protocol has tremendously reduced synthetic effort and tedious purification for preparing the monosaccharide building blocks. The yield has been increased and the quantity could be scaled up.
- This invention has used Dr. Hung’s procedure to synthesize L-idose derivatives in a highly efficient manner.
- This invention has employed a common intermediate to prepare three D-glucosamine-derived building blocks.
- This invention has well controlled the desired glycosidic bond formation and avoided the possible isomers as well as purification problems.
- This invention has developed an efficient route to establish the pentasaccharide skeleton which is different from the known methods.
- This invention only requires 28 synthetic steps which are a half of GSK’s protocol. The overall yield has been increased and the cost has been reduced a lot. It has a high potential to compete to the world market.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
